Cargando…

Severity of sepsis in patients with acute purulent destructive pulmonary disease depending on the presence of type 2 diabetes: impact on the forecast

Detalles Bibliográficos
Autores principales:	Babobekov, A, Babadjanov, B, Atakov, S, Shalaeva, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273912/ http://dx.doi.org/10.1186/cc14010

Ejemplares similares

Impact of purulent complications and sepsis on cardiovascular system in patients with type 2 diabetes
por: Shalaeva, E, et al.
Publicado: (2014)

Risk factors and incidence of mediastinitis in patients with lung abscess and sepsis
por: Shalaeva, E, et al.
Publicado: (2014)

Virulent Purulent Sepsis
Publicado: (1887)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

Presence of infection in patients with presumed sepsis at the time of ICU admission
por: Klouwenberg, PMC Klein, et al.
Publicado: (2014)

Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
por: Dalm, Virgil, et al.
Publicado: (2013)

Pulmonary macrophage migration inhibitory factor: an important contributor to age-dependent inflammation in sepsis
por: Linge, Helena, et al.
Publicado: (2008)

Impact of the Surviving Sepsis Campaign implementation on severe sepsis outcome
por: Silva, E
Publicado: (2011)

Costs of severe sepsis according to the guidelines of the 'Surviving Sepsis Campaign'
por: de Anda, G Vazquez, et al.
Publicado: (2005)

Epidemiology of severe sepsis in India
por: Todi, S, et al.
Publicado: (2007)

Epidemiology of severe sepsis in India
por: Chatterjee, S, et al.
Publicado: (2009)

Inhibition of Syndecan-4 by therapeutic antibodies reduces TNFα dependent joint destruction in mice
por: Stratis, Athanasios, et al.
Publicado: (2012)

Epidemiology of severe sepsis in India: an update
por: Todi, S, et al.
Publicado: (2010)

Obesity and inflammatory markers in severe sepsis
por: Simon, P, et al.
Publicado: (2013)

Tissue oxygenation in patients with severe sepsis
por: Oei, A, et al.
Publicado: (2014)

Systemic symptoms as markers for severity in sepsis
por: Edman-Wallér, J, et al.
Publicado: (2015)

Prognostic factors of severe sepsis: a result of Korean sepsis registry system
por: Chun, Byung-Chul, et al.
Publicado: (2008)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Inhibitory role of the acute phase proteins on neutrophil migration in severe sepsis
por: Spiller, F, et al.
Publicado: (2009)

Presence of bacterial infection and duration of antibiotic therapy in patients with standardized sepsis detection in the emergency department
por: Minderhoud, TC, et al.
Publicado: (2014)

Effects of PPARγ in dendritic cells during severe sepsis and sepsis-induced immunosuppression
por: Molinaro, Raphael, et al.
Publicado: (2013)

Vd/Vt test in the detection of pulmonary dysfunction in sepsis
por: Cala, K, et al.
Publicado: (2004)

Evaluation of the source of infection in patients with severe sepsis
por: Kauss, IAM, et al.
Publicado: (2007)

The endothelial glycocalyx degenerates with increasing sepsis severity
por: Köhler, M, et al.
Publicado: (2011)

Cerebral vasoreactivity is not impaired in patients with severe sepsis
por: Szatmári, S, et al.
Publicado: (2011)

Induction of severe Staphylococcus aureus sepsis in pigs
por: Iburg, TM, et al.
Publicado: (2009)

Are phenylcarboxylic acids really markers in severe sepsis?
por: Beloborodova, NV, et al.
Publicado: (2009)

Molecular diagnosis of severe bacterial sepsis in children
por: Merisescu, M, et al.
Publicado: (2012)

Consequences of cytomegalovirus reactivation in patients with severe sepsis
por: Heininger, A, et al.
Publicado: (2007)

Subcutaneous glucose monitoring in patients with severe sepsis
por: Mader, JK, et al.
Publicado: (2007)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Severe abdominal sepsis in the intensive care unit
por: Morar, R
Publicado: (2004)

Antioxidant enzyme activities in patients with severe sepsis
por: Novak, F, et al.
Publicado: (2004)

Severe sepsis and septic shock in Croatian ICUs
por: Gornik, I, et al.
Publicado: (2006)

Methemoglobin level as an indicator for disease severity in sepsis
por: Schuerholz, T, et al.
Publicado: (2008)

IL-1-driven cartilage and bone destruction are dependent on Toll-like receptor (TLR) 4, but not TLR2
por: Abdollahi-Roodsaz, S, et al.
Publicado: (2005)

The impact of protocolized sepsis order set on the process of care in patients with severe sepsis/septic shock
por: Afessa, Bekele, et al.
Publicado: (2007)

Compliance with the sepsis resuscitation bundle in patients with severe sepsis and septic shock admitted to Scottish ICUs
por: Davidson, JA, et al.
Publicado: (2012)

Impact of the sepsis bundle strategy on the outcomes of the patients suffering from severe sepsis and septic shock
por: Wang, Z
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g77mttkfq03mmog9gsnn97nn79